About Tute Genomics
Tute Genomics is a company based in Los Angeles (United States) founded in 2012 was acquired by PierianDx in October 2016. Tute Genomics has raised $7.39 million across 4 funding rounds from investors including Tencent, Intermountain Healthcare and Wellfound. Tute Genomics has completed 1 acquisition, including Knome. Tute Genomics operates in a competitive market with competitors including Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others.
- Headquarter Los Angeles, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.39 M (USD)
in 4 rounds
-
Latest Funding Round
$868.53 K (USD), Series A
Oct 27, 2015
-
Investors
Tencent
& 6 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
PierianDx
(Oct 11, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Tute Genomics
Tute Genomics has successfully raised a total of $7.39M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $868.53 thousand completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Tute Genomics
Tute Genomics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Intermountain Healthcare and Wellfound.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech investments are directed by Eurovestech across multiple sectors.
|
Locked | Locked | Locked | |
|
Healthcare startups are accelerated via a five-day program by Healthbox.
|
Locked | Locked | Locked | |
|
Investments are directed toward early-stage tech startups by Album VC.
|
Locked | Locked | Locked |
Investor details for Tute Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tute Genomics
Tute Genomics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Knome.
Investment portfolio details for Tute Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Human genome interpretation software and services are provided.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Tute Genomics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Tute Genomics
Detailed financials for Tute Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tute Genomics Comparisons
Peer comparison for Tute Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tute Genomics
Tute Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
Detailed competitors of Tute Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tute Genomics
Complete news archive for Tute Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tute Genomics
Tute Genomics was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Tute Genomics is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Tute Genomics is a funded company, having raised a total of $7.39M across 4 funding rounds to date.
Tute Genomics offers clinical-grade web-based application, powered by machine learning algorithms that allow researchers and clinicians to analyze, utilize, and interpret human genomes data for scientific discovery and individualized treatment. The companys platform also supports disease gene finding and biomarker discovery, as well as provides machine intelligence, genome management, data filtration for streamlined output, and association analysis. Its platform serves pharmaceuticals and biotechnology companies, genetics laboratories, and research centers.
Tute Genomics's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
Tute Genomics has made 1 acquisition, including Knome.
Tute Genomics has 7 investors. Key investors include Tencent, Intermountain Healthcare, Wellfound, PierianDx, and Eurovestech.